VRNA

65.97

5.26% -3.66

Dopo l'orario di chiusura: 66.15 0.18 +0.27%

Verona Pharma Plc Adr (VRNA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$69.63

Aprire:

$69.85

Volume 24 ore:

1.35M

Relative Volume:

1.05

Capitalizzazione di mercato:

$5.88B

Reddito:

Utile/perdita netta:

$-153.72M

Rapporto P/E:

-32.98

EPS:

-2

Flusso di cassa netto:

$-103.81M

1 W Prestazione:

+0.56%

1M Prestazione:

+11.85%

6M Prestazione:

+142.45%

1 anno Prestazione:

+262.67%

Intervallo 1D:

$65.63

$70.40

Intervallo di 1 settimana:

$62.22

$70.40

Portata 52W:

$11.39

$70.40

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Nome

Verona Pharma Plc Adr

Settore

Healthcare (1189)

Industria

Biotechnology (682)

Telefono

011-44-0-2032834200

Indirizzo

3 MORE LONDON RIVERSIDE, LONDON

Dipendente

Cinguettio

@VeronaPharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

VRNA's Discussions on Twitter

Confronta VRNA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VRNA Verona Pharma Plc Adr	65.97	5.88B	0	-153.72M	-103.81M	-2.00
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-10	Iniziato	ROTH MKM	Buy
2024-10-03	Iniziato	Wells Fargo	Overweight
2023-05-22	Ripresa	Jefferies	Buy
2022-09-19	Ripresa	Wedbush	Outperform
2022-08-26	Iniziato	Piper Sandler	Overweight
2021-09-13	Iniziato	H.C. Wainwright	Buy
2020-08-25	Iniziato	Jefferies	Buy
2020-08-10	Iniziato	Canaccord Genuity	Buy
2019-04-18	Iniziato	BTIG Research	Buy

Mostra tutto

Verona Pharma Plc Adr Borsa (VRNA) Ultime notizie

Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada

Feb 27, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com

Feb 27, 2025

Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK

Feb 27, 2025

Feb 21, 2025

A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily

Feb 21, 2025

Feb 13, 2025

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - GlobeNewswire Inc.

Feb 13, 2025

Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 - Investing.com India

Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa

Feb 12, 2025

Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa

Feb 12, 2025

Feb 11, 2025

Investor’s Delight: Lithium Americas Corp (NewCo) (LAC) Closes Weak at 2.97, Down -1.98 - The Dwinnex

Feb 11, 2025

There is no doubt that Verona Pharma Plc ADR (VRNA) ticks all the boxes. - SETE News

Feb 11, 2025

Analyzing Verona Pharma Plc ADR (VRNA) After Recent Trading Activity - Knox Daily

Feb 11, 2025

Rumble Inc (RUM)’s Market Momentum: Closing Strong at 12.25, Down -3.92 - The Dwinnex

Feb 11, 2025

Market Recap Check: Lineage Cell Therapeutics Inc (LCTX)’s Negative Finish at 0.66, Up/Down -2.12 - The Dwinnex

Feb 11, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: OrganiGram Holdings Inc (OGI) - SETE News

Feb 11, 2025

Feb 06, 2025

Are Smart Investors Making the Right Decision? Verona Pharma Plc ADR (VRNA) - SETE News

Feb 06, 2025

Healthy Upside Potential: Solidion Technology Inc (STI) - SETE News

Feb 06, 2025

Feb 05, 2025

Stock Surge: XPO Inc (XPO) Closes at 131.50, Marking a 2.24 Increase/Decrease - The Dwinnex

Feb 05, 2025

Closing Figures Unveiled: Diageo plc ADR (DEO) Drop -0.84, Closes at 115.95 - The Dwinnex

Feb 05, 2025

Market Watch Highlights: Verona Pharma Plc ADR (VRNA) Ends on an Upturn Note at 59.94 - The Dwinnex

Feb 05, 2025

Market Momentum Report: Lemonade Inc (LMND)’s Positive Close at 33.99 - The Dwinnex

Feb 05, 2025

Checking in on Verona Pharma Plc ADR (VRNA) after recent insiders movement - Knox Daily

Feb 04, 2025

A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News

Feb 04, 2025

Have you been able to find a good deal on Verona Pharma Plc ADR’s shares? - US Post News

Feb 04, 2025

The Agilon Health Inc (AGL) had a good session last reading, didn’t it? - US Post News

Feb 04, 2025

How should investors view Relay Therapeutics Inc (RLAY)? - US Post News

Feb 04, 2025

Jan 21, 2025

Verona Pharma stock target upgraded, retains buy on Q4 results By Investing.com - Investing.com South Africa

Jan 21, 2025

Jan 17, 2025

Looking For A Top Momentum Pick? Why Valley National Bancorp (NASDAQ: VLY) Is A Great Choice - Stocks Register

Jan 17, 2025

Hertz Global Holdings Inc (NASDAQ: HTZ): Overvalued Compared To Others? - Stocks Register

Jan 17, 2025